Clinical Research Directory

Inclusion Criteria: * Written informed consent provided prior to study initiation. * Confirmed diagnosis of Fibromyalgia Syndrome according to the ACR (American College of Rheumatology) criteria. * Age between 18 and 60 years. * Stable pharmacological treatment for fibromyalgia for at least 4 weeks prior to enrollment, with agreement not to modify dosage during the study unless strictly necessary. * Ability to comprehend, speak, and read Italian to complete self-reported outcome measures and participate in group sessions. * Ability to provide written consent and follow study procedures. Exclusion Criteria: * Severe cognitive impairment or active psychiatric disorders (e.g., severe clinical depression, psychosis, bipolar disorder) preventing participation in group sessions or self-report evaluations. * Severe cardiovascular, respiratory, metabolic, or systemic diseases that contraindicate low-to-moderate physical activity. * Concomitant autoimmune or inflammatory rheumatic diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis). * Presence of severe neurological disorders (e.g., Parkinson's disease, multiple sclerosis, stroke sequelae). * Regular participation in structured mindfulness, yoga, or body awareness programs within the last 6 months. * Ongoing pregnancy or planned pregnancy during the study period.